Goals & Objectives
Education & Resources▼
Find a Clinician
Refer a Colleague
Which of the following is correct, according to
Dr Pelin Batur's webcast
50 Shades of Low Sexual Desire in Women
, regarding treatment of female hypoactive sexual desire disorder (HSDD)?
a. Testosterone is FDA approved to treat HSDD in postmenopausal women
b. Bremelanotide is an FDA approved, on demand medication
c. Flibanserin is an FDA approved, on demand medication
d. All of the above
Your answers are confidential and will be used for educational purposes only.